PHASE I II TRIAL OF 2-STEP RADIOIMMUNOTHERAPY IN MEDULLARY-THYROID CANCER (MTC) USING BISPECIFIC ANTI-CEA/ANTI-DTPA-IN ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN/

Authors
BODERE FK BARDET S VUILLEZ JP BARDIES M GAUTHEROT E ROUVIER E BARBET J CHATAL JF
Citation
Fk. Bodere et al., PHASE I II TRIAL OF 2-STEP RADIOIMMUNOTHERAPY IN MEDULLARY-THYROID CANCER (MTC) USING BISPECIFIC ANTI-CEA/ANTI-DTPA-IN ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN/, The Journal of nuclear medicine, 39(5), 1998, pp. 1084-1084
Citations number
NO
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
The Journal of nuclear medicine → ACNP
ISSN journal
01615505
Volume
39
Issue
5
Year of publication
1998
Supplement
S
Pages
1084 - 1084
Database
ISI
SICI code
0161-5505(1998)39:5<1084:PIITO2>2.0.ZU;2-4